Results for: actos

Actos

Former Actos User Developed Bladder Cancer After Just Four Months on the Drug

June 19, 2012 - A Louisiana man has filed a lawsuit alleging that Actos (generic: pioglitazone) caused him to develop bladder cancer just four months after initiating a regimen with the widely-prescribed diabetes drug. Although most lawsuits of this type...

Actos

Actos Bladder Cancer Statute of Limitations May Expire This Week

June 14, 2012 - If Takeda Pharmaceuticals’ attorneys have their way, patients diagnosed with bladder cancer after using Actos will face a deadline for filing their lawsuit tomorrow, if the drug was prescribed or taken in a state with a...

Actos

Actos Linked to Vision Problems

According to the results of a new study, using Takeda’s controversial diabetes drug Actos (generic: pioglitazone) may significantly increase the risk of developing a severe eye problem known as macular edema. This condition causes the macula region of the eye...

Actos

New Research Confirms Actos Bladder Cancer Risk

June 4, 2012 - Two recent studies appear to confirm a mountain of previous evidence indicating a link between Takeda’s blockbuster diabetes drug Actos (generic: pioglitazone) and bladder cancer. The research, which was published last week in the British Medical...

Actos

Bladder Cancer Risk Prompts Actos Restriction in Ontario

The Canadian province of Ontario is limiting patient access to Takeda’s controversial diabetes medication Actos (generic: pioglitazone) due to the risk of bladder cancer that has become increasingly linked to the drug. The Ontario Public Drug (OPD) program has announced...

Actos

Actos Bladder Cancer Warning Added in Canada

April 24, 2012 - Last week, Health Canada announced that it was requiring new bladder cancer warnings to be added to labels of Takeda’s controversial diabetes drug Actos (generic: pioglitazone). The move came following a safety review of the drug...

Actos

Actos Bladder Cancer Lawsuits Consolidated in Louisiana

According to a judicial panel, lawsuits involving Takeda’s blockbuster diabetes drug Actos (pioglitazone) will be centralized before one judge in Louisiana federal court. The complaints allege that patients who use Actos are at an increased risk of developing bladder cancer,...

Actos

Takeda May Face 10,000 Actos Bladder Cancer Lawsuits

According to recent estimates, Asia’s largest pharmaceutical manufacturer may face as many as 10,000 legal claims against its blockbuster diabetes drug Actos in the United States alone. An FDA analysis of a study sponsored by Takeda found that Actos users...

Actos and Cancer Lawsuit

Actos and Cancer

Takeda’s popular diabetes medication Actos (pioglitazone) has recently been linked in studies to an increased risk for bladder cancer in patients who take the drug for an extended period of time. Free Confidential Lawsuit Evaluation:If you or a loved one...

Actos Bladder Cancer Lawsuit

EMA Recommends New Actos Bladder Cancer Warnings

In light of convincing new scientific evidence, the European Medicines Agency (EMA) has issued a press release recommending new contraindications and warnings for Takeda’s controversial diabetes drug Actos (pioglitazone) to reduce the risk of bladder cancer in certain users. The...